- Home
- SVRE vs KTTA Comparison
SVRE vs KTTA Comparison
Compare SVRE & KTTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SVRE
- KTTA
- Stock Information
- Founded
- SVRE 2014
- KTTA 2020
- Country
- SVRE Israel
- KTTA United States
- Employees
- SVRE N/A
- KTTA N/A
- Industry
- SVRE
- KTTA Biotechnology: Pharmaceutical Preparations
- Sector
- SVRE
- KTTA Health Care
- Exchange
- SVRE Nasdaq
- KTTA Nasdaq
- Market Cap
- SVRE 2.8M
- KTTA 3.2M
- IPO Year
- SVRE 2022
- KTTA 2021
- Fundamental
- Price
- SVRE $0.88
- KTTA $2.48
- Analyst Decision
- SVRE
- KTTA
- Analyst Count
- SVRE 0
- KTTA 0
- Target Price
- SVRE N/A
- KTTA N/A
- AVG Volume (30 Days)
- SVRE 644.4K
- KTTA 43.9K
- Earning Date
- SVRE 08-27-2024
- KTTA 11-13-2024
- Dividend Yield
- SVRE N/A
- KTTA N/A
- EPS Growth
- SVRE N/A
- KTTA N/A
- EPS
- SVRE N/A
- KTTA N/A
- Revenue
- SVRE $458,952.00
- KTTA N/A
- Revenue This Year
- SVRE N/A
- KTTA N/A
- Revenue Next Year
- SVRE $422.52
- KTTA N/A
- P/E Ratio
- SVRE N/A
- KTTA N/A
- Revenue Growth
- SVRE N/A
- KTTA N/A
- 52 Week Low
- SVRE $0.80
- KTTA $2.20
- 52 Week High
- SVRE $27.00
- KTTA $9.25
- Technical
- Relative Strength Index (RSI)
- SVRE 42.74
- KTTA 38.84
- Support Level
- SVRE $0.80
- KTTA $2.20
- Resistance Level
- SVRE $0.94
- KTTA $2.61
- Average True Range (ATR)
- SVRE 0.10
- KTTA 0.28
- MACD
- SVRE 0.00
- KTTA -0.03
- Stochastic Oscillator
- SVRE 15.23
- KTTA 24.35
About SVRE SaverOne 2014 Ltd.
Saverone 2014 Ltd provides driver protection solutions. The company develops and deploys ADAS technologies for transportation safety and driver assistance. The company's product restricts the driver from surfing, communicating, and receiving alerts while driving. The Company has developed a system that provides a solution to the problem of distracted driving caused by cell phone use, which endangers the driver, passengers, other drivers on the road, and pedestrians.
About KTTA Pasithea Therapeutics Corp.
Pasithea Therapeutics Corp is a biotechnology company. It is focused on the discovery, research, and development of treatments for central nervous system (CNS) disorders and other diseases, including RASopathies. It leveraging in the fields of neuroscience, translational medicine, and drug development. Its pipeline includes Neurofibromatosis Type 1, Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis (MS), and Schizophrenia.